Goldman Sachs Says Crowd Misreads This Medical Robotics Giant
The crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
Explore Visualizing Your Financial Goals to turn abstract aims into concrete visuals, aiding commitment and progress tracking.
21,085 articlesThe crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
ServiceNow stock slipped today amid broader software fears and AI budget debates. Explore the drivers, what it means ...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Opendoor stock popped today amid optimism about profitability progress and better unit economics. This article breaks...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
In March 2026, a new market roundup highlights the best direct access brokers for active traders, underscoring speed,...
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...
Curious about whether Blue Owl Capital can outperform the market? This guide breaks down what to watch, how to analyz...
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
A small robotaxi-focused company is breaking out with strong revenue growth, offering a compelling contrast to Tesla....